Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 339

1.

Molecular basis of distinct oestrogen responses in endometrial and breast cancer.

Baxter E, Windloch K, Kelly G, Lee JS, Gannon F, Brennan DJ.

Endocr Relat Cancer. 2019 Jan 1;26(1):31-46. doi: 10.1530/ERC-17-0563.

PMID:
30121621
2.

Combinatorial Prg4 and Il-1ra Gene Therapy Protects Against Hyperalgesia and Cartilage Degeneration in Post-Traumatic Osteoarthritis.

Stone A, Grol MW, Ruan MZC, Dawson B, Chen Y, Jiang MM, Song IW, Jayaram P, Cela R, Gannon F, Lee BHL.

Hum Gene Ther. 2019 Feb;30(2):225-235. doi: 10.1089/hum.2018.106. Epub 2018 Oct 17.

PMID:
30070147
3.

Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.

Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, Lee BHL, Guse K.

Arthritis Rheumatol. 2018 Nov;70(11):1757-1768. doi: 10.1002/art.40668. Epub 2018 Sep 10.

PMID:
30044894
4.

mTORC1 Signaling is a Critical Regulator of Postnatal Tendon Development.

Lim J, Munivez E, Jiang MM, Song IW, Gannon F, Keene DR, Schweitzer R, Lee BH, Joeng KS.

Sci Rep. 2017 Dec 7;7(1):17175. doi: 10.1038/s41598-017-17384-0.

5.

The ERC: from before then to anniversary celebrations.

Gannon F.

EMBO Rep. 2017 Nov;18(11):1873-1874. doi: 10.15252/embr.201745025. Epub 2017 Oct 11. No abstract available.

6.

Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization.

Narayanan A, Khanchandani P, Borkar RM, Ambati CR, Roy A, Han X, Bhoskar RN, Ragampeta S, Gannon F, Mysorekar V, Karanam B, V SM, Sivaramakrishnan V.

Sci Rep. 2017 Sep 6;7(1):10721. doi: 10.1038/s41598-017-10817-w.

7.

G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.

Casciello F, Al-Ejeh F, Kelly G, Brennan DJ, Ngiow SF, Young A, Stoll T, Windloch K, Hill MM, Smyth MJ, Gannon F, Lee JS.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7077-7082. doi: 10.1073/pnas.1618706114. Epub 2017 Jun 19.

8.

Bilateral adrenal histoplasmosis in an immunocompetent man from Texas.

Rog CJ, Rosen DG, Gannon FH.

Med Mycol Case Rep. 2016 Nov 29;14:4-7. eCollection 2016 Dec.

9.

Brexit and research: goodbye EU money and colleagues?

Gannon F.

EMBO Rep. 2016 Sep;17(9):1237-8. doi: 10.15252/embr.201643057. Epub 2016 Jul 27. No abstract available.

10.

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.

Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, Massaquoi T, Gandi R, Joseph S, Osman HK, Brooks TJ, Simpson AJ, Goodfellow I, Thorne L, Arias A, Merson L, Castle L, Howell-Jones R, Pardinaz-Solis R, Hope-Gill B, Ferri M, Grove J, Kowalski M, Stepniewska K, Lang T, Whitehead J, Olliaro P, Samai M, Horby PW; RAPIDE-TKM trial team.

PLoS Med. 2016 Apr 19;13(4):e1001997. doi: 10.1371/journal.pmed.1001997. eCollection 2016 Apr.

11.

Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice.

Rajagopal A, Homan EP, Joeng KS, Suzuki M, Bertin T, Cela R, Munivez E, Dawson B, Jiang MM, Gannon F, Crawford S, Lee BH.

Mol Genet Metab. 2016 Mar;117(3):378-82. doi: 10.1016/j.ymgme.2015.11.015. Epub 2015 Dec 2.

12.

Functional Role of G9a Histone Methyltransferase in Cancer.

Casciello F, Windloch K, Gannon F, Lee JS.

Front Immunol. 2015 Sep 25;6:487. doi: 10.3389/fimmu.2015.00487. eCollection 2015. Review.

13.

Lip sync conferences.

Gannon F.

EMBO Rep. 2015 Sep;16(9):1051. doi: 10.15252/embr.201540909. Epub 2015 Jul 21. No abstract available.

14.

The steps from translatable to translational research.

Gannon F.

EMBO Rep. 2014 Nov;15(11):1107-8. doi: 10.15252/embr.201439587. Epub 2014 Oct 8. No abstract available.

15.

Notch activation as a driver of osteogenic sarcoma.

Tao J, Jiang MM, Jiang L, Salvo JS, Zeng HC, Dawson B, Bertin TK, Rao PH, Chen R, Donehower LA, Gannon F, Lee BH.

Cancer Cell. 2014 Sep 8;26(3):390-401. doi: 10.1016/j.ccr.2014.07.023.

16.

Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.

Pathiraja TN, Nayak SR, Xi Y, Jiang S, Garee JP, Edwards DP, Lee AV, Chen J, Shea MJ, Santen RJ, Gannon F, Kangaspeska S, Jelinek J, Issa JP, Richer JK, Elias A, McIlroy M, Young LS, Davidson NE, Schiff R, Li W, Oesterreich S.

Sci Transl Med. 2014 Mar 26;6(229):229ra41. doi: 10.1126/scitranslmed.3008326.

17.

Epigenetic regulation in cancer progression.

Baxter E, Windloch K, Gannon F, Lee JS.

Cell Biosci. 2014 Aug 19;4:45. doi: 10.1186/2045-3701-4-45. eCollection 2014. Review.

18.

Proteoglycan 4 expression protects against the development of osteoarthritis.

Ruan MZ, Erez A, Guse K, Dawson B, Bertin T, Chen Y, Jiang MM, Yustein J, Gannon F, Lee BH.

Sci Transl Med. 2013 Mar 13;5(176):176ra34. doi: 10.1126/scitranslmed.3005409.

19.

Quantitative imaging of murine osteoarthritic cartilage by phase-contrast micro-computed tomography.

Ruan MZ, Dawson B, Jiang MM, Gannon F, Heggeness M, Lee BH.

Arthritis Rheum. 2013 Feb;65(2):388-96. doi: 10.1002/art.37766.

20.

Histologic identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels.

Salisbury E, Hipp J, Olmsted-Davis EA, Davis AR, Heggeness MH, Gannon FH.

Hum Pathol. 2012 Dec;43(12):2213-22. doi: 10.1016/j.humpath.2012.03.013. Epub 2012 Jun 27.

21.

Prospective randomized phase II Trial of accelerated reepithelialization of superficial second-degree burn wounds using extracorporeal shock wave therapy.

Ottomann C, Stojadinovic A, Lavin PT, Gannon FH, Heggeness MH, Thiele R, Schaden W, Hartmann B.

Ann Surg. 2012 Jan;255(1):23-9. doi: 10.1097/SLA.0b013e318227b3c0.

PMID:
21775883
22.

Sensory nerve induced inflammation contributes to heterotopic ossification.

Salisbury E, Rodenberg E, Sonnet C, Hipp J, Gannon FH, Vadakkan TJ, Dickinson ME, Olmsted-Davis EA, Davis AR.

J Cell Biochem. 2011 Oct;112(10):2748-58. doi: 10.1002/jcb.23225.

23.

Newsmaker interview: Frank Gannon. Ireland's departing research chief on Irish and European science. Interview by John Travis.

Gannon F.

Science. 2010 Sep 3;329(5996):1139. doi: 10.1126/science.329.5996.1139-a. No abstract available.

PMID:
20813930
24.

Protocol for the examination of specimens from patients with tumors of soft tissue.

Rubin BP, Cooper K, Fletcher CD, Folpe AL, Gannon FH, Hunt JL, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Reith JD, Qualman SJ, Rosenberg AE, Weiss SW, Krausz T; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e31-9. doi: 10.1043/1543-2165-134.4.e31. No abstract available.

PMID:
20367297
25.

Protocol for the examination of specimens from patients with tumors of bone.

Rubin BP, Antonescu CR, Gannon FH, Hunt JL, Inwards CY, Klein MJ, Kneisl JS, Montag AG, Peabody TD, Reith JD, Rosenberg AE, Krausz T; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e1-7. doi: 10.1043/1543-2165-134.4.e1. No abstract available.

PMID:
20367293
26.

Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification.

Dilling CF, Wada AM, Lazard ZW, Salisbury EA, Gannon FH, Vadakkan TJ, Gao L, Hirschi K, Dickinson ME, Davis AR, Olmsted-Davis EA.

J Bone Miner Res. 2010 May;25(5):1147-56. doi: 10.1359/jbmr.091031.

27.

E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elements.

Bretschneider N, Kangaspeska S, Seifert M, Reid G, Gannon F, Denger S.

Mol Oncol. 2008 Aug;2(2):182-90. doi: 10.1016/j.molonc.2008.05.004. Epub 2008 May 29.

28.

On our watch.

Gannon F.

EMBO Rep. 2009 Mar;10(3):193. doi: 10.1038/embor.2009.11. No abstract available.

29.

Convergence.

Gannon F.

EMBO Rep. 2009 Feb;10(2):103. doi: 10.1038/embor.2009.1. No abstract available.

30.

Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.

Johnsen SA, Güngör C, Prenzel T, Riethdorf S, Riethdorf L, Taniguchi-Ishigaki N, Rau T, Tursun B, Furlow JD, Sauter G, Scheffner M, Pantel K, Gannon F, Bach I.

Cancer Res. 2009 Jan 1;69(1):128-36. doi: 10.1158/0008-5472.CAN-08-1630.

31.

A letter to Darwin.

Gannon F.

EMBO Rep. 2009 Jan;10(1):1. doi: 10.1038/embor.2008.239. No abstract available.

32.

Burnout.

Gannon F.

EMBO Rep. 2008 Dec;9(12):1157. doi: 10.1038/embor.2008.210. No abstract available.

33.

Energy and biologists.

Gannon F.

EMBO Rep. 2008 Nov;9(11):1055. doi: 10.1038/embor.2008.194. No abstract available.

34.

Text mining for biology--the way forward: opinions from leading scientists.

Altman RB, Bergman CM, Blake J, Blaschke C, Cohen A, Gannon F, Grivell L, Hahn U, Hersh W, Hirschman L, Jensen LJ, Krallinger M, Mons B, O'Donoghue SI, Peitsch MC, Rebholz-Schuhmann D, Shatkay H, Valencia A.

Genome Biol. 2008;9 Suppl 2:S7. doi: 10.1186/gb-2008-9-s2-s7. Epub 2008 Sep 1.

35.

Bullies.

Gannon F.

EMBO Rep. 2008 Oct;9(10):937. doi: 10.1038/embor.2008.177. No abstract available.

36.

The missing link.

Gannon F.

EMBO Rep. 2008 Sep;9(9):819. doi: 10.1038/embor.2008.152. No abstract available.

37.

Familiar faces.

Gannon F.

EMBO Rep. 2008 Aug;9(8):699. doi: 10.1038/embor.2008.141. No abstract available.

38.

Different perspectives.

Gannon F.

EMBO Rep. 2008 Jul;9(7):591. doi: 10.1038/embor.2008.124. No abstract available.

39.

Variations on complexity.

Gannon F, Pariente N.

EMBO Rep. 2008 Jun;9(6):493. doi: 10.1038/embor.2008.85. No abstract available.

40.

Dynamics of estrogen receptor-mediated transcriptional activation of responsive genes in vivo: apprehending transcription in four dimensions.

Métivier R, Huet G, Gallais R, Finot L, Petit F, Tiffoche C, Mérot Y, LePéron C, Reid G, Penot G, Demay F, Gannon F, Flouriot G, Salbert G.

Adv Exp Med Biol. 2008;617:129-38. doi: 10.1007/978-0-387-69080-3_12. Review. No abstract available.

PMID:
18497037
41.

Paralysed by perfection.

Gannon F.

EMBO Rep. 2008 May;9(5):401. doi: 10.1038/embor.2008.66. No abstract available.

42.

Expression of the estrogen receptor during differentiation of human osteoclasts.

Denger S, Reid G, Gannon F.

Steroids. 2008 Aug;73(7):765-74. doi: 10.1016/j.steroids.2008.02.013. Epub 2008 Mar 18.

PMID:
18406438
43.

Measuring success.

Gannon F.

EMBO Rep. 2008 Apr;9(4):301. doi: 10.1038/embor.2008.47. No abstract available.

44.

Transient cyclical methylation of promoter DNA.

Kangaspeska S, Stride B, Métivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, Benes V, Gannon F, Reid G.

Nature. 2008 Mar 6;452(7183):112-5. doi: 10.1038/nature06640.

PMID:
18322535
45.

Cyclical DNA methylation of a transcriptionally active promoter.

Métivier R, Gallais R, Tiffoche C, Le Péron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, Benes V, Jeltsch A, Gannon F, Salbert G.

Nature. 2008 Mar 6;452(7183):45-50. doi: 10.1038/nature06544. Erratum in: Nature. 2010 Jan 21;463(7279):384.

PMID:
18322525
46.

Language barriers.

Gannon F.

EMBO Rep. 2008 Mar;9(3):207. doi: 10.1038/embor.2008.14. No abstract available.

47.

The pipeline.

Gannon F.

EMBO Rep. 2008 Jan;9(1):1. doi: 10.1038/sj.embor.7401156. No abstract available.

48.

Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.

Bretschneider N, Brand H, Miller N, Lowery AJ, Kerin MJ, Gannon F, Denger S.

Cancer Res. 2008 Jan 1;68(1):106-14. doi: 10.1158/0008-5472.CAN-07-5647.

49.

Hope, hype and hypocrisy.

Gannon F.

EMBO Rep. 2007 Dec;8(12):1087. No abstract available.

50.

Barriers to translation of research.

Gannon F.

Mol Oncol. 2007 Dec;1(3):244-5. doi: 10.1016/j.molonc.2007.10.002. Epub 2007 Oct 14. No abstract available.

Supplemental Content

Loading ...
Support Center